Stay updated with breaking news from Withdraw Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On February 23, the Food and Drug Administration (FDA) withdrew approval of Pepaxto (melphalan flufenamide), a drug that it had previously granted accelerated approval for treatment of...
On April 5, 2023, the U.S. Food and Drug Administration ("FDA") announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection ("Makena"...
U.S. Food and Drug Administration FDA announced decision to withdraw approval of Makena® hydroxyprogesterone caproate injection, drug approved in 2011 to reduce risk of preterm birth in certain pregnant women.
On April 5, 2023, the U.S. Food and Drug Administration (“FDA”) announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection (“Makena”) – a drug...
This report provides a snapshot of the US Executive Branch priorities via daily schedules and the prior day press releases. POTUS Joseph Biden VPOTUS Kamala Harris The White House The Office of Management and Budget Department of Defense Department of State USAID and More